Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter K Moore

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Shock (Augusta, Ga.)|September 23, 2003
The abdominal compartment syndrome as a second insult during systemic neutrophil priming provokes multiple organ injuryJoao B Rezende-Neto, Ernest E Moore, Tomohiko Masuno, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
Journal of the American College of Surgeons|May 19, 2020
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 InfectionFranklin L Wright, Thomas O Vogler, Ernest E Moore, et al.
World Journal of Emergency Surgery : WJES|April 22, 2020
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisRashikh Choudhury, Christopher D Barrett, Hunter B Moore, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
High tPA Activity but Absent PAI-1 and Plasminogen Function Early in Intrapleural Lytic TherapyElizabeth R Maginot, Peter K Moore, Cesar Davila-Chapa, et al.
The Journal of Trauma and Acute Care Surgery|February 8, 2012
Future of acute care surgery: a perspective from the next generationHunter B Moore, Peter K Moore, Abigail R Grant, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2020
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trialHunter B Moore, Christopher D Barrett, Ernest E Moore, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 28, 2023
Single-cell RNA sequencing reveals unique monocyte-derived interstitial macrophage subsets during lipopolysaccharide-induced acute lung inflammationPeter K Moore, Kelsey C Anderson, Shannon A McManus, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 7, 2025
Needle of Death Thromboelastography Tracings in Severely Bleeding Trauma Patients: A Novel Predictor of Hemorrhagic Blood Failure and Futile Resuscitation?Connor M Bunch, Mark M Walsh, Ernest E Moore, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2020
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and reviewChristopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Shock (Augusta, Ga.)|September 23, 2003
The abdominal compartment syndrome as a second insult during systemic neutrophil priming provokes multiple organ injuryJoao B Rezende-Neto, Ernest E Moore, Tomohiko Masuno, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
Journal of the American College of Surgeons|May 19, 2020
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 InfectionFranklin L Wright, Thomas O Vogler, Ernest E Moore, et al.
World Journal of Emergency Surgery : WJES|April 22, 2020
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisRashikh Choudhury, Christopher D Barrett, Hunter B Moore, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
High tPA Activity but Absent PAI-1 and Plasminogen Function Early in Intrapleural Lytic TherapyElizabeth R Maginot, Peter K Moore, Cesar Davila-Chapa, et al.
The Journal of Trauma and Acute Care Surgery|February 8, 2012
Future of acute care surgery: a perspective from the next generationHunter B Moore, Peter K Moore, Abigail R Grant, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2020
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trialHunter B Moore, Christopher D Barrett, Ernest E Moore, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 28, 2023
Single-cell RNA sequencing reveals unique monocyte-derived interstitial macrophage subsets during lipopolysaccharide-induced acute lung inflammationPeter K Moore, Kelsey C Anderson, Shannon A McManus, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 7, 2025
Needle of Death Thromboelastography Tracings in Severely Bleeding Trauma Patients: A Novel Predictor of Hemorrhagic Blood Failure and Futile Resuscitation?Connor M Bunch, Mark M Walsh, Ernest E Moore, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2020
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and reviewChristopher D Barrett, Hunter B Moore, Ernest E Moore, et al.
Pageof 4